A Phase I Study of Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma

Overview of attention for article published in Oncologist, September 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 1 public wall post.

Lessons Learned HyperAcute Renal immunotherapy was well tolerated and demonstrated antitumor activity in patients requiring…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.